
[Federal Register: March 23, 2010 (Volume 75, Number 55)]
[Rules and Regulations]               
[Page 13678]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23mr10-11]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 3

[Docket No. FDA-2010-N-0010]

 
Product Jurisdiction; Change of Address and Telephone Number; 
Technical Amendment

Agency: Food and Drug Administration, HHS.

Action: Final rule; technical amendment.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending its 
regulations to reflect a change in the address and telephone number for 
the Office of Combination Products (OCP). This action is editorial in 
nature and is intended to improve the accuracy of the agency's 
regulations.

DATES: Effective Date: April 19, 2010.

FOR FURTHER INFORMATION CONTACT: John Barlow Weiner, Office of 
Combination Products, Food and Drug Administration, 10903 New Hampshire 
Ave., Bldg. 32, rm. 5130, Silver Spring, MD 20993-0002, 301-796-8930. 
To confirm that this change of address and telephone number has 
occurred, please see our Web site at www.fda.gov/CombinationProducts/
default.htm.

SUPPLEMENTARY INFORMATION: FDA is amending its regulations in 21 CFR 
part 3 to reflect a change in the address and telephone number for OCP. 
Publication of this document constitutes final action on this change 
under the Administrative Procedure Act (5 U.S.C. 553). Notice and 
public procedures are unnecessary because FDA is merely updating 
nonsubstantive content.

List of Subjects in 21 CFR Part 3

    Administrative practice and procedure, Biologics, Combination 
products, Drugs, Medical devices.

0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
3 is amended as follows:

PART 3--PRODUCT JURISDICTION

0
1. The authority citation for 21 CFR part 3 continues to read as 
follows:

    Authority: 21 U.S.C. 321, 351, 353, 355, 360, 360c-360f, 360h-
360j, 360gg-360ss, 360bbb-2, 371(a), 379e, 381, 394; 42 U.S.C. 216, 
262, 264.


Sec.  3.6  [Amended]

0
2. Section 3.6 is amended by removing ``(HFG-3), Food and Drug 
Administration, 15800 Crabbs Branch Way, suite 200, Rockville, MD 
20855, 301-427-1934''and by adding in its place ``Food and Drug 
Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5129, Silver 
Spring, MD 20993-0002, 301-796-8930,''.

    Dated: March 17, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-6246 Filed 3-22-10; 8:45 am]
BILLING CODE 4160-01-S

